跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Glucovance - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Glucovance
Approved
STANDARD
Glucovance
Merck Sante s.a.s.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
53a4037d891a2f8b
Company
Merck Sante s.a.s.
Type
Standard
Approval Details
Approval Id
53a4037d891a2f8b
Drug Approval Philippines Name
Glucovance
Product Name
Glucovance
Registration Number
DR-XY28382
Brand Name
Glucovance
Generic Name
Metformin (As Hydrochloride) + Glibenclamide
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg/2.5 mg
Manufacturer
Merck Sante s.a.s.
Importer
Merck. Inc
Company Detail Path
/organization/merck-sante-s-a-s
Issuance Date
28 September 2022
Expiry Date
05 March 2028
Pharmacologic Category
Blood Glucose Lowering Drugs (Biguanides/Sulfonylureas)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
53a4037d891a2f8b
Type
Standard
Back to Philippines FDA Approvals